Prof. Yu Peng | Gastroenterology | Research Excellence Award
Professor | Xiangya Hospital Central South University | China
Prof. Yu Peng is a clinician-scientist specializing in inflammatory bowel disease, with a strong focus on Crohn’s disease. His research integrates clinical medicine with translational and microbiome-based approaches to improve diagnosis, nutritional assessment, and therapeutic outcomes. He has contributed influential studies on gut microbiota perturbation, nutritional indices, biologic therapy response, and innovative adjunctive treatments such as hyperbaric oxygen therapy. Through high-impact publications in leading gastroenterology and medical journals, his work has provided new insights into disease mechanisms and optimized treatment strategies, offering practical guidance for personalized and evidence-based management of inflammatory bowel disease.
Finding Appropriate Timing for the Combination of Azathioprine and Infliximab
– Clinical and Experimental Medicine, 2025
High-Density Lipoprotein as a Predictive Biomarker for Infliximab Efficacy in Crohn’s Disease
– Journal of Inflammation Research, 2025
IgG4-Related Disease Involving Intestinal Tract and Orbital Cavity
– Journal of Gastroenterology and Hepatology, 2023